Item Type | Name |
Academic Article
|
Multiple modes of a7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.
|
Concept
|
Animals
|
Concept
|
Behavior, Animal
|
Concept
|
Mammary Glands, Animal
|
Concept
|
Animals, Genetically Modified
|
Concept
|
Mammary Neoplasms, Animal
|
Concept
|
Disease Models, Animal
|
Academic Article
|
Heterocyclic aminoparthenolide derivatives modulate G(2)-M cell cycle progression during Xenopus oocyte maturation.
|
Academic Article
|
Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.
|
Academic Article
|
Heck products of parthenolide and melampomagnolide-B as anticancer modulators that modify cell cycle progression.
|
Academic Article
|
Novel cytoprotective inhibitors for apoptotic endonuclease G.
|
Academic Article
|
Novel high-throughput deoxyribonuclease 1 assay.
|
Academic Article
|
Synthesis and biological evaluation of novel 4,5-disubstituted 2H-1,2,3-triazoles as cis-constrained analogues of combretastatin A-4.
|
Academic Article
|
In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.
|
Academic Article
|
Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).
|
Academic Article
|
Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier.
|
Academic Article
|
An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine.
|
Academic Article
|
NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols.
|
Academic Article
|
The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusion.
|
Academic Article
|
Transdermal delivery of naltrexone and its active metabolite 6-beta-naltrexol in human skin in vitro and guinea pigs in vivo.
|
Academic Article
|
N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
|
Academic Article
|
Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
|
Academic Article
|
N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices.
|
Academic Article
|
N,N-disubstituted piperazines: synthesis and affinities at alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors.
|
Academic Article
|
Evaluation of O(3alpha)-, O(21)-di-(N(1)-methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl) 17alpha-hydroxy-5beta-pregnan-20-one as a novel potential antiangiogenic codrug.
|
Academic Article
|
Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.
|
Academic Article
|
meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
|
Academic Article
|
Effects of norketamine enantiomers in rodent models of persistent pain.
|
Academic Article
|
Lobelane decreases methamphetamine self-administration in rats.
|
Academic Article
|
Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.
|
Academic Article
|
Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras.
|
Academic Article
|
Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.
|
Academic Article
|
In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.
|
Academic Article
|
Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
|
Academic Article
|
Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands.
|
Academic Article
|
Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.
|
Academic Article
|
In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs.
|
Academic Article
|
Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter.
|
Academic Article
|
3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
|
Academic Article
|
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
|
Academic Article
|
Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.
|
Academic Article
|
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
|
Academic Article
|
N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
|
Academic Article
|
Effect of pH on sublingual absorption of oxycodone hydrochloride.
|
Academic Article
|
The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery.
|
Academic Article
|
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
|
Academic Article
|
Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
|
Academic Article
|
Identification and synthesis of novel alkaloids from the root system of Nicotiana tabacum: affinity for neuronal nicotinic acetylcholine receptors.
|
Academic Article
|
Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.
|
Academic Article
|
Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
|
Academic Article
|
Regiospecific and conformationally restrained analogs of melphalan and DL-2-NAM-7 and their affinities for the large neutral amino acid transporter (system LAT1) of the blood-brain barrier.
|
Academic Article
|
The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitization.
|
Academic Article
|
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-?B and generating reactive oxygen species.
|
Academic Article
|
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.
|
Academic Article
|
Nicotinic receptor antagonists as treatments for nicotine abuse.
|
Academic Article
|
Scopolamine sublingual spray: an alternative route of delivery for the treatment of motion sickness.
|
Academic Article
|
Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.
|
Academic Article
|
Selective inhibition of acetylcholine-evoked responses of alpha7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists.
|
Academic Article
|
Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptake.
|
Academic Article
|
The mechanism of L-canavanine cytotoxicity: arginyl tRNA synthetase as a novel target for anticancer drug discovery.
|
Academic Article
|
The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.
|
Academic Article
|
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.
|
Academic Article
|
Pharmacokinetics of the novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide in the rat.
|
Academic Article
|
Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach.
|
Academic Article
|
Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
|
Academic Article
|
Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2.
|
Academic Article
|
QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.
|
Academic Article
|
Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine release.
|
Academic Article
|
Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.
|
Academic Article
|
Synthesis and evaluation of chromenyl barbiturates and thiobarbiturates as potential antitubercular agents.
|
Academic Article
|
Vesicular monoamine transporter 2: role as a novel target for drug development.
|
Academic Article
|
A pharmacokinetic study on Z-(+/-)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent.
|
Academic Article
|
Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.
|
Academic Article
|
Quinlobelane: a water-soluble lobelane analogue and inhibitor of VMAT2.
|
Academic Article
|
Phenyl ring-substituted lobelane analogs: inhibition of [?H]dopamine uptake at the vesicular monoamine transporter-2.
|
Academic Article
|
Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands.
|
Academic Article
|
Aplysinopsin analogs: Synthesis and anti-proliferative activity of substituted (Z)-5-(N-benzylindol-3-ylmethylene)imidazolidine-2,4-diones.
|
Academic Article
|
bPiDI: a novel selective a6?2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
|
Academic Article
|
Inhibition of NF-?B and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays.
|
Academic Article
|
Antihyperglycemic profile of erinidine isolated from Hunteria umbellata seed.
|
Academic Article
|
Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.
|
Academic Article
|
Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners.
|
Academic Article
|
Indolizidine (-)-235B' and related structural analogs: discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release.
|
Academic Article
|
The NADH oxidase ENOX1, a critical mediator of endothelial cell radiosensitization, is crucial for vascular development.
|
Academic Article
|
N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomes.
|
Academic Article
|
Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation.
|
Academic Article
|
Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
|
Academic Article
|
Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.
|
Academic Article
|
Computational neural network analysis of the affinity of N-n-alkylnicotinium salts for the alpha4beta2* nicotinic acetylcholine receptor.
|
Academic Article
|
Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
|
Academic Article
|
Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).
|
Academic Article
|
Nicotinic receptor-based therapeutics and candidates for smoking cessation.
|
Academic Article
|
The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
|
Academic Article
|
Lobelane analogues as novel ligands for the vesicular monoamine transporter-2.
|
Academic Article
|
The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats.
|
Academic Article
|
Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.
|
Academic Article
|
Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation.
|
Academic Article
|
Stereocontrolled synthesis and pharmacological evaluation of cis-2,6-diphenethyl-1-azabicyclo[2.2.2]octanes as lobelane analogues.
|
Academic Article
|
Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain.
|
Academic Article
|
KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells.
|
Academic Article
|
Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats.
|
Academic Article
|
Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.
|
Academic Article
|
Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.
|
Academic Article
|
The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.
|
Academic Article
|
In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity.
|
Academic Article
|
The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
|
Academic Article
|
GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine.
|
Academic Article
|
Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells.
|
Academic Article
|
Discovery of non-peptide, small molecule antagonists of a9a10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.
|
Academic Article
|
Pyrrolidine analogs of GZ-793A: synthesis and evaluation as inhibitors of the vesicular monoamine transporter-2 (VMAT2).
|
Academic Article
|
Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs.
|
Academic Article
|
The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats.
|
Academic Article
|
Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.
|
Academic Article
|
The novel small molecule a9a10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.
|
Academic Article
|
Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.
|
Academic Article
|
Novel small molecule a9a10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.
|
Academic Article
|
Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents.
|
Academic Article
|
r-bPiDI, an a6?2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
|
Academic Article
|
Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
|
Academic Article
|
Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
|
Academic Article
|
Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes.
|
Academic Article
|
A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.
|
Academic Article
|
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.
|
Academic Article
|
Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.
|
Academic Article
|
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
|
Academic Article
|
1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2.
|
Academic Article
|
Targeting Enox1 in tumor stroma increases the efficacy of fractionated radiotherapy.
|
Academic Article
|
N-[11CH3]Dimethylaminoparthenolide (DMAPT) uptake into orthotopic 9LSF glioblastoma tumors in the rat.
|
Academic Article
|
Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer.
|
Academic Article
|
Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancer.
|
Academic Article
|
GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2.
|
Academic Article
|
Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.
|
Academic Article
|
Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
|
Academic Article
|
Evaluation of Analgesia, Tolerance, and the Mechanism of Action of Morphine-6-O-Sulfate Across Multiple Pain Modalities in Sprague-Dawley Rats.
|
Academic Article
|
Stability studies of potent opioid analgesic, morphine-6-O-sulfate in various buffers and biological matrices by HPLC-DAD analysis.
|
Academic Article
|
The analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain.
|
Academic Article
|
Persistent Activation of NF-?B in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.
|
Academic Article
|
Interaction between morphine and norketamine enantiomers in rodent models of nociception.
|
Academic Article
|
Bioavailability of ??-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits.
|
Academic Article
|
Toxicity of dipyridyl compounds and related compounds.
|
Academic Article
|
Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.
|
Academic Article
|
Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development.
|
Academic Article
|
A novel chemical delivery system comprising an ocular sustained release formulation of a 3alpha, 17alpha, 21-trihydroxy-5beta-pregnan-20-one-BIS-5-fluorouracil [correction of flourouracil] codrug.
|
Academic Article
|
Development of a GC-MS assay for the determination of fentanyl pharmacokinetics in rabbit plasma after sublingual spray delivery.
|
Academic Article
|
DMAPT inhibits NF-?B activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
|
Academic Article
|
Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast Cancer.
|
Academic Article
|
Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathy.
|
Academic Article
|
New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.
|
Academic Article
|
Pinprick hypo- and hyperalgesia in diabetic rats: Can diet content affect experimental outcome?
|
Academic Article
|
Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
|
Academic Article
|
Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence.
|
Academic Article
|
An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic a6?2* antagonist r-bPiDI.
|
Academic Article
|
Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with ?9-Tetrahydrocannabinol and JWH-018.
|
Academic Article
|
GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.
|
Academic Article
|
Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence.
|
Academic Article
|
A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer's Disease.
|
Academic Article
|
Deuteration of the farnesyl terminal methyl groups of d-tocotrienol and its effects on the metabolic stability and ability of inducing G-CSF production.
|
Academic Article
|
A pharmacokinetic study of morphine-6-O-sulfate in rat plasma and brain.
|
Academic Article
|
Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
|
Academic Article
|
Selected Antihypertensive Agents and Their Fixed-Dose Combinations Effectively Ameliorate Trastuzumab-Mediated Cardiac Dysfunction In Rats.
|
Academic Article
|
High flux novel polymeric membrane for renal applications.
|